{"text": "\n\n\n\nAsian stocks declined, suggesting a pause in a rally that lifted regional equities to the highest levels in at least a decade. The dollar slipped and the yen and Australian dollar edged higher, after a report that Senate Republican leaders are considering a delay in the implementation of a corporate-tax cut.The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index\u2019s performance in India, fell 0.11 percent to 10,399 as of 7:00 a.m.Short on time? Well, then listen to this podcast for a quick summary of the article!\n\n\n\n\n\n\n\n\n\n\n\nDayBreak\n\n\n\n\n\n\n\n\n\n\n\nHere\u2019s a quick look at all that could influence equities on Wednesday.\n\n\n\n\n\n\nGlobal Cues\n\n\n\n\n\n\nU.S. stocks fell as investors turned their attention to fiscal policy, with tax writers from the House of Representatives expected to hammer out their plan this week.\n\n\n\n\n\n#BQMarketsNow | U.S. stocks slide, dollar gains as taxes take focus.https://t.co/pkhjaxJDmF pic.twitter.com/OyHVk4It4d\u2014 BloombergQuint (@BloombergQuint) November 8, 2017\n\n\n\n\n\n\nAsian Cues\n\n\n\n\n\n\nThe Nikkei 225 fell 0.4 percent in early trade. The Topix index declined 0.3 percent.The S&P/ASX 200 Index lost 0.2 percent, and South Korea\u2019s Kospi index was down 0.1 percent.Futures on Hong Kong\u2019s Hang Seng Index fell 0.5 percent.Futures on the S&P 500 fell 0.2 percent. The underlying gauge ended virtually unchanged Tuesday.The MSCI Asia Pacific Index gained 0.9 percent Tuesday to the highest in about 10 years. The MSCI Emerging Markets Index closed at the highest since mid-2011.Here are some key upcoming events this week:U.S. consumer sentiment probably cooled in early November from a more than 13-year high; the University of Michigan\u2019s report is out on Friday.OPEC releases its World Oil Outlook.Thailand is expected to leave interest rates unchanged on Wednesday. Other central banks meeting on monetary policy this week: Argentina, Mexico, New Zealand and Malaysia.China October trade is slated for Wednesday.The European Commission\u2019s chief Brexit negotiator Michel Barnier and U.K. Brexit Secretary David Davis resume talks.Earnings season continues with announcements from Walt Disney Co., Adidas AG, and Siemens AG. European financial companies set to report include Banca Monte dei Paschi di Siena SpA, Credit Agricole SA, Allianz SE and Zurich Insurance Group AG.\n\n\n\n\n\n\nCommodity Cues\n\n\n\n\n\n\nWest Texas Intermediate crude traded at $57.02 a barrel.Gold was steady at $1,277.51 an ounce.Copper fell 2.2 percent Tuesday to about $3.09 a pound, the lowest in about a month. The Bloomberg Commodity Index dropped for the first time in seven days Tuesday.ICE sugar ended higher for third day at 14.72 $/lb; up 1.10 percent.Shanghai ExchangeSteel snaps six-day losing streak; down 0.67 percentAluminium trades lower for fifth consecutive session; down 1.24 percentZinc trades lower; down 1.57 percentCopper trades lower; down 1.87 percentRubber trades lower; down 0.9 percent\n\n\n\n\n\n\nIndian ADRs\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEarnings To Watch\n\n\n\n\n\n\nArvindAshok LeylandBalkrishna IndustriesBharat ForgeBombay DyeingCESCChennai PetroleumFuture ConsumerIRB InfrastructureMahanagar GasMas FinancialPetronet LNGPidilite IndustriesShree CementThermaxVa Tech WabagVoltasWelspun India\n\n\n\n\n\n\nResults Announced\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDhampur Sugar (Q2FY18, YoY)Revenue up 15 percent at Rs 802 croreNet profit up 62 percent at Rs 60 croreEBITDA up 14 percent at Rs 121 croreMargin at 15.1 percent versus 15.2 percentJohnson Controls-Hitachi Air Conditioning India (Q2FY18, YoY)Revenue up 11 percent at Rs 317 croreNet loss of Rs 0.2 crore from loss of Rs 5.6 croreEBITDA at Rs 9.5 crore versus EBITDA loss of Rs 2 croreMargin at 3 percent versus -0.7 percentHealthCare Global Enterprises Ltd (Q2FY18, YoY)Revenue up 21 percent at Rs 211 croreNet profit doubled to Rs 10 croreEBITDA up 26 percent at Rs 31.5 croreMargin at 14.9 percent versus 14.4 percentButterfly Gandhimathi Appliances (Q2FY18, YoY)Revenue up 29.7 percent at Rs 201 croreNet profit at Rs 11.5 croreEBITDA at Rs 17 croreMargin at 8.45 percent versus 5.8 percentL&T Technology Services Ltd (Q2FY18, QoQ)Revenue up 9.5 percent at Rs 901 croreNet profit up 25.5 percent at Rs 12.3 croreEBIT up 10 percent at Rs 138 croreMargin at 15.3 percent versus 15.2 percentEssel Propack (Q2FY18, YoY)Revenue up 11.6 percent at Rs 640 croreNet profit down 26 percent at Rs 52.5 croreEBITDA up 20.5 percent at Rs 132.5 croreMargin at 20.7 percent versus 19.2 percentDCM Shriram (Q2FY18, YoY)Revenue up 17.5 percent at Rs 1,605 croreNet profit up 88 percent at Rs 172 croreEBITDA up 138.5 percent at Rs 291 croreMargin at 18.1 percent versus 8.9 percentIndian Overseas Bank (Q2FY18, YoY)Net interest income up 18.3 percent at Rs 1520.4 croreNet loss of Rs 1,222 crore versus loss of Rs 765 croreGross NPA at 22.73 percent versus 23.6 percent (QoQ)Net NPA at 13.86 percent versus 14.9 percent (QoQ)Liberty Shoes (Q2FY18, YoY)Revenue up 17 percent at Rs 126 croreNet profit down 35 percent at Rs 1.1 croreEBITDA up 4 percent at Rs 9.6 croreMargin at 7.6 percent versus 8.5 percentGlaxo Consumer (Q2FY18, YoY)Revenue up 3 percent at Rs 1,115 croreNet profit up 4 percent at Rs 192 croreEBITDA up 6.5 percent at Rs 261.6 croreMargin at 23.5 percent versus 22.7 percentHimatsingka Seide (Q2FY18, YoY)Revenue up 10 percent at Rs 578.5 croreNet profit up 10 percent at Rs 50.6 croreEBITDA up 9 percent at Rs 99.5 croreMargin at 17.2 percent versus 17.3 percentFilatex India (Q2FY18, YoY)Revenue up 8 percent at Rs 414.5 croreNet profit up 12.5 percent at Rs 13.5 croreEBITDA up 6 percent at Rs 36 croreMargin at 8.7 percent versus 8.9 percentMonte Carlo (Q2FY18, YoY)Revenue up 12 percent at Rs 138 croreNet profit up 15.55 percent at Rs 15.6 croreEBITDA up 8 percent at Rs 26 croreMargin at 18.8 percent versus 19.5 percentDalmia Bharat (Q2FY18, YoY)Revenue up 7 percent at Rs 1834 croreNet profit up 235.5 percent at Rs 104 croreEBITDA up 5 percent at Rs 442 croreMargin at 24.1 percent versus 24.6 percentHuhtamaki PPL (Q2FY18, YoY)Revenue down 2 percent at Rs 546 croreNet profit up 15 percent at Rs 19 croreEBITDA up 11 percent at Rs 62 croreMargin at 11.35 percent versus 10 percentJindal Saw (Q2FY18, YoY)Revenue down 0.75 percent at Rs 13.2 croreNet profit up 20 percent at Rs 0.6 croreEBITDA down 12.5 percent at Rs 2.1 croreMargin at 15.9 percent versus 18.0 percentHindusthan National Glass (Q2FY18, YoY)Revenue up 7 percent at Rs 431 croreNet loss of Rs 71 crore versus profit of Rs 38 croreEBITDA down 32 percent at Rs 32 croreMargin at 7.4 percent versus 11.7 percentAdlabs Entertainment (Q2FY18, YoY)Revenue down 2.7 percent at Rs 36 croreNet loss of Rs 57 crore versus loss of Rs 44 croreEBITDA loss at Rs 2 croreMargin at -5.6 percent versus 2.7 percentFinolex Cables (Q2FY18, YoY)Revenue up 24.9 percent at Rs 702 croreNet profit down 5 percent at Rs 100 croreEBITDA down 0.5 percent at Rs 98.5 croreMargin at 14.0 percent versus 17.6 percentManappuram Finance (Q2FY18, YoY)Net interest income up 6.9 percent at Rs 528 croreNet profit down 5.3 percent at Rs 170.2 croreTata Coffee (Q2FY18, YoY)Revenue up 4 percent at Rs 382 croreNet profit down 23 percent at Rs 23 croreEBITDA down 15.5 percent at Rs 71 croreMargin at 18.6 percent versus 22.88 percentRSWM (Q2FY18, YoY)Revenue down 7.7 percent at Rs 686 croreNet loss of Rs 2.5 crore versus profit of Rs 27 croreEBITDA down 47 percent at Rs 49 croreMargin at 7.1 percent versus 12.5 percent\n\n\n\n\n\n\nStocks To Watch\n\n\n\n\n\n\nSun Pharmaceutical\u2019s subsidiary Taro Pharma reported a strong performance during the previous quarter.Axis Bank board to meet on Nov. 10 to consider raising funds.Three Pillars PTE to sell up to 19.99 crore shares of Bharti Airtel in the range of Rs 473-480 per share.Adlabs to sell Novotel Imagica Khopoli Hotel for Rs 213 crore to Bright Star. It will also sell Walkwater stake to Blue Haven for Rs 150 crore.Indoco Remedies to resume manufacturing of ophthalmic products at Goa unit II.Akzo Nobel to divest India's specialty chemical business, likely to garner for Rs 320 crore.JSW Energy got an order to supply 200 MW power to Karnataka from November 8 - May 31.DCM Shriram to invest around Rs 500 crore in sugar business to increase overall capacity.NMDC mulls bidding for $9 billion mine (Financial Express)\n\n\n\n\n\n\nBulk Deals\n\n\n\n\n\n\nDelta CorpSmall Cap World Fund bought 1.02 crore shares or 3.8 percent equity stake at Rs 279.2 each (average).Rekha Rakesh Jhunjhunwala sold 25 lakh shares or 0.9 percent equity stake at Rs 280.35 each.Aarti J Mody Trust sold 18.2 lakh shares or 0.7 percent equity stake at Rs 280.4 each.Anjali J Mody Trust sold 18.2 lakh shares or 0.7 percent equity stake at Rs 280.37 each.Aro GraniteDilipkumar Lakhi bought 82,848 shares or 0.5 percent equity stake at Rs 67.16 each.Greenlam IndustriesDovetail India Fund bought 2.08 lakh shares or 0.9 percent equity stake at Rs 998 each.Morgan Stanley Mauritius sold 2.03 lakh shares or 0.8 percent equity stake at Rs 998 each.MPSICICI Lombard General Insurance bought 6.33 lakh shares or 3.4 percent equity stake at Rs 585 each.Goldman Sachs India Fund sold 6.33 lakh shares or 3.4 percent equity stake at Rs 585.01 each.PDS MultinationalEQ India Fund bought 1.45 lakh shares or 0.6 percent equity stake at Rs 235.08 each.Selan ExplorationKIFS Enterprises bought 1 lakh shares or 0.6 percent equity stake at Rs 256.96 each.Veto SwitchgearPromoter Veto Electropowers India sold 2.50 lakh shares or 1.4 percent equity stake at Rs 210 each.Ajmera RealtyPromoter Shashikant S Ajmera bought 2.56 lakh shares or 0.7 percent equity stake at Rs 293.79 each.Shashikant S. Ajmera HUF sold 2.56 lakh shares or 0.7 percent or equity stake at Rs 293.81 each.\n\n\n\n\n\n\nIPOHDFC Standard Life Insurance IPO continues on day 2. The issue was subscribed 0.46 times on day 1.\n\n\n\n\n\n\nWho\u2019s Meeting Whom?\n\n\n\n\n\n\nVakrangee to meet analysts and investors in Hong Kong on Nov. 8-9.Cipla to meet investors on Nov. 9-10 and Dec. 4.TVS Motor to meet Wellington EM Fund on Nov. 22-23.Blue Star to meet Steadview capital on Nov. 8.Bharat Forge to meet Axis Capital on Nov. 9, CLSA on Nov. 14 and UBS on Nov. 16.Indiabulls Housing Finance to conduct road show with Nomura from Nov. 6-9 in Hong Kong and Tokyo.\n\n\n\n\n\n\nRupee\n\n\n\n\n\n\nRupee closed at 65.03/$ on Tuesday from 64.68/$ on Monday\n\n\n\n\n\n\nTop Gainers and Losers\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nIndex Trends\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nF&O Cues\n\n\n\n\n\n\nNifty November futures closed at 10,409.9, premium of 59.9 points from 37.7 points.November contracts: Nifty open interest down 5 percent; Bank Nifty open interest down 1 percent.India VIX closed 1.6 percent higher at 13.2.Max open interest for November series at 10,500 Call (open interest at 41.9 lakh, up 28 percent).Max open interest for November series at 10,000 Put (open interest at 56.7 lakh, down 9 percent).\n\n\n\n\n\n\nF&O Ban\n\n\n\n\n\n\nIn ban: DHFL, HDIL , Indiabulls Real Estate, India Cement, Infibeam, JSW Energy, Reliance Communication, Wockhardt.New in ban: India Cement.Only intraday positions can be taken in stocks which are in F&O ban. In case of a rollover of these intraday positions, there is a penalty\n\n\n\n\n\n\nPut-Call Ratio\n\n\n\n\n\n\nNifty PCR at 1.43 from 1.55.Nifty Bank PCR at 1.01 from 1.20.\n\n\n\n\n\n\nStocks Seeing High Open Interest Change\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFund Flows\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBrokerage Radar\n\n\n\n\n\n\nMorgan Stanley on BanksAxis: Maintained \u2018Overweight\u2019; hiked price target to Rs 630 from Rs 555.ICICI: Maintained \u2018Overweight\u2019; hiked price target to Rs 365 from Rs 345.SBI: Maintained \u2018Overweight\u2019; hiked price target to Rs 370 from Rs 360.Risk-reward significantly favourable to investors, even from current levels.Recap will clean up the books for the large corporate lenders.Expect some pick-up in core pre-provision operating profit as net interest margins improve.Return on assets for Axis Bank and ICICI Bank to improve to 1.5 percent and 0.9 percent for SBI.CLSA on LupinMaintained \u2018Buy\u2019; Cut price target to Rs 1,030 from Rs 1,260.Goa and Indore plants account for 70 percent of U.S. sales and have 50 pending approvals.Lupin is looking to site transfer 12 products on a priority basis.Despite the warning letter, expect Lupin to maintain current U.S. sales of $200 million/quarter and overall operating margin of 20 percent.Cut earnings per share estimates for the next two financial years by 15 percent and 20 percent respectively on lower U.S. sales.Credit Suisse on LupinUpgraded to \u2018Neutral\u2019 from \u2018Underperform\u2019; Cut price target to Rs 875 from Rs 900.Upgrade because of limited downside; Contribution of the ex-US business is worth Rs 600 per share.Warning letter at Goa and Indore does not impact the key product Levothyroxine.Due to delayed launches, cut earnings per share estimates for the next financial year by 8 percent.Next event is release of warning letter details which is expected by next week.Morgan Stanley on LupinDowngraded to \u2018Equalweight\u2019 from \u2018Overweight\u2019; Cut price target to Rs 847 from Rs 1,219.Warning letter to delay niche approvals by 9-15 months, leading to earnings headwinds.Cut net profit estimates for the next two financial years by 24 percent and 22 percent respectively to account for lower U.S. business.Expect two-quarter delay of levothyroxime to the second half of the next financial year.CLSA on CiplaMaintained \u2018Buy\u2019; hiked price target to Rs 730 from Rs 655.U.S. sales ramp-up to drive the previous quarter\u2019s earnings growth.Strong India business, U.S. ramp-up and cost control to expand margins over next few years.Cost control to show up further but U.S. sales growth is key .Raised earnings per share estimates by 3-5 percent to reflect results for the current financial year.Credit Suisse on CiplaMaintained \u2018Outperform\u2019; hiked price target to Rs 700 from Rs 600.U.S. upside has started due to Renvela launch in the previous quarter; Cost control continues.Expect second half to be strong led by accrual of Renvela cash flows, approvals for couple of products and India growth.Inventory days should further improve by 4-5 days from current 8-10 days.Cipla has the lowest price erosion risk and is the biggest beneficiary of faster approvals.UBS on BHELMaintained \u2018Sell\u2019 with price target of Rs 49.Revenues missed estimates during the previous quarter, resulting in operating loss.Abundant untied thermal capacity, thermal capacity under construction and sharp decline in renewable tariffs to keep order inflows low.Medium term order inflows unlikely to surpass revenue estimates of the current and next financial years.Expect stagnation in order book, slow momentum in the non-power business and weak of return on equity.Macquarie on BHELMaintained \u2018Underperform\u2019 with price target of Rs 72.Bulk of the positives, like restart of stalled projects, L1 pipeline is factored in.With slow revenue turnaround, the entire operating leverage story falls flat.Structural headwinds remain with renewables, NPA in thermal power and under-utilisation of existing plants.UBS on EmamiMaintained \u2018Buy\u2019; Hiked price target to Rs 1,500 from Rs 1,300.Expect volume growth to bounce back to 10-12 percent from a low-growth phase.Emami\u2019s investment in direct distribution and cash & carry to augur well over the next three years.Well positioned for a rural recovery; Herbal preference to help retain consumer preference.New product launches are keys to sustained revenue momentum.CLSA on L&T TechnologyMaintained \u2018Buy\u2019; hiked price target to Rs 980 from Rs 950.Stellar rise in revenue during the previous quarter, deal wins continue but softer margin.Increase revenue estimates or the financial years till March 2020 by 2-4 percent and cut margin estimate for by 80-120 basis points for the period.L&T Technology remains an attractive play on secular growth in engineering services.\n\n\n\n", "ticker": "BM", "title": "\n\n\n        All You Need To Know Going Into Trade On November 8\n      \n\n", "time": "2017-11-08 01:43:00"}